Search

Your search keyword '"Venturutti, Leandro"' showing total 34 results

Search Constraints

Start Over You searched for: Author "Venturutti, Leandro" Remove constraint Author: "Venturutti, Leandro"
34 results on '"Venturutti, Leandro"'

Search Results

1. Profiling Dynamic Patterns of Single‐Cell Motility.

3. TBL1XR1 Mutations Drive Extranodal Lymphoma by Inducing a Pro-tumorigenic Memory Fate

4. Mutant EZH2 Induces a Pre-malignant Lymphoma Niche by Reprogramming the Immune Response

5. TRAF3 loss-of-function reveals the noncanonical NF-κB pathway as a therapeutic target in diffuse large B cell lymphoma

6. Nuclear PDCD4 Expression Defines a Subset of Luminal B-Like Breast Cancers with Good Prognosis

7. Data from An Aged/Autoimmune B-cell Program Defines the Early Transformation of Extranodal Lymphomas

8. Table S1 from An Aged/Autoimmune B-cell Program Defines the Early Transformation of Extranodal Lymphomas

9. Figures S1-S7 from An Aged/Autoimmune B-cell Program Defines the Early Transformation of Extranodal Lymphomas

10. TRAF3 Loss-of-Function Reveals the Non-Canonical NF-Κb Pathway As a Therapeutic Target in Diffuse Large B-Cell Lymphoma

11. An Aged/Autoimmune B-cell Program Defines the Early Transformation of Extranodal Lymphomas

12. Profiling emergent behaviors from single-cell motility

17. Nuclear PDCD4 Expression Predicts Good Clinical Outcome in Luminal A-Like and Luminal B-Like Breast Cancer Subtypes

19. Abstract PO-42: TBL1XR1 mutations drive extranodal lymphomagenesis by inducing a protumorigenic memory B-cell fate

20. SUN-122 Nuclear PDCD4 Expression Predicts Good Clinical Outcome in Luminal A-Like and Luminal B-Like Breast Cancer Subtypes

21. Additional file 1 of Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer

22. Rol de los micro-ARN 21 y 16 en la diseminación metastásica y resistencia a terapias dirigidas en el cáncer de mama ErbB-2 positivo

23. Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer

25. Heregulin Co-opts PR transcriptional action via Stat3 role as a coregulator to drive cancer growth

26. TNFα-Induced Mucin 4 Expression Elicits Trastuzumab Resistance in HER2-Positive Breast Cancer

28. Abstract 2265: Stat3 and ErbB-2 interaction in breast cancer metastasis

34. An Aged/Autoimmune B-cell Program Defines the Early Transformation of Extranodal Lymphomas.

Catalog

Books, media, physical & digital resources